Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer
Citations Over TimeTop 1% of 2017 papers
Abstract
Diseases at the molecular level are complex and patient dependent, necessitating development of strategies that enable precision treatment to optimize clinical outcomes. Organoid technology has recently been shown to have the potential to recapitulate the in vivo characteristics of the original individual's tissue in a three-dimensional in vitro culture system. Here, we present a quantitative mass-spectrometry-based proteomic analysis and a comparative transcriptomic analysis of human colorectal tumor and healthy organoids derived, in parallel, from seven patients. Although gene and protein signatures can be derived to distinguish the tumor organoid population from healthy organoids, our data clearly reveal that each patient possesses a distinct organoid signature at the proteomic level. We demonstrate that a personalized patient-specific organoid proteome profile can be related to the diagnosis of a patient and with future development contribute to the generation of personalized therapies.
Related Papers
- → Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture(2020)50 cited
- → Culture and differentiation of rabbit intestinal organoids and organoid-derived cell monolayers(2021)28 cited
- → Microfabricated dynamic brain organoid cocultures to assess the effects of surface geometry on assembloid formation(2024)6 cited
- → Optimal, Large-Scale Propagation of Mouse Mammary Tumor Organoids(2020)13 cited
- → [Research progress on vascularization of organoids].(2023)1 cited